Pfizer recalls all lots of anti-smoking drug over carcinogen presence
Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.
1 minute readA person walks past a Pfizer logo amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 1, 2021. REUTERS/Carlo AllegriSept 16 (Reuters) - Pfizer Inc(PFE.N)said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.
The drugmaker paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far.Pfizer asked wholesalers and distributors on Thursday to stop the use and distribution of the tablets immediately.The company said there was no immediate risk to patients
taking Chantix, but advised them to consult with their health care provider to check the availability of alternative treatments.Chantix was approved by the FDA in May 2006 as a prescription medication to help adults aged 18 and over quit smoking and is typically used for 12 to 24 weeks. headtopics.com
Reporting by Amruta Khandekar; Editing by Saumyadeb ChakrabartyOur Standards:More from ReutersSign up for our newsletterSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox. Read more: Reuters Top News »
Pelosi upbeat on Biden deal but Manchin pans billionaire tax
House Speaker Nancy Pelosi is telling colleagues that Democrats are in “pretty good shape” on President Joe Biden’s sweeping domestic policy plan and a related $1 trillion infrastructure bill
You'd better not quit smoking, son
New Pfizer data makes case for booster shots 6 months after primary dosesBREAKING: Pfizer demonstrates what it sees as proof that third shot will be both safe and necessary for most Americans to take, arguing that immunity wanes over time—regardless of any new variant of concern—according to new data released by the FDA. Bring it on. Excellent news. $$$$$$$$$$
New Pfizer data makes case for booster shots 6 months after primary dosesThe Food and Drug Administration on Wednesday released new data from Pfizer's submitted application to approve booster doses of its Covid-19 vaccine. In it, Pfizer demonstrates what it sees as proof that third shot will be both safe and necessary for most Americans to take, arguing that immunity wanes over time -- regardless of any new variant of concern. It comes two days ahead of a critical juncture in the COVID-19 vaccine booster approval process: Friday, the Food and Drug Administration's independent advisory committee (VRBPAC) is set to convene to review and discuss the latest data on potential booster doses of the Pfizer vaccine. Recently, I made a chair. When I was finished, I thought it was a good chair. I submitted it to the Indiana fine woodworking association, who felt it merited consideration for an award. It's been a real whirlwind.
Pfizer says data suggests vaccine boosters needed for waning vaccine efficacyPfizer told the FDA Wednesday that data from its clinical trials suggests a third shot of its coronavirus vaccine may be necessary six months after the second dose because of waning efficacy.Why it matters: The FDA's advisory committee on Friday is expected to review Pfizer's clinical trials and other supporting and conflicting data on coronavirus booster shots and make recommendations on whether more Americans 16 years and older should receive an extra dose.Stay on top of the latest market tren ❤️ It is Your Responsibility to take the Sane and Reasonable Steps to Protect: ✔️ Yourself ✔️ Your Family ✔️ Other People ➡️ Follow CDCgov, US_FDA, NIH, WHCOVIDResponse and WHO Guidelines ✅ Get Fully Vaccinated for COVID19 ✅ Wear a Mask 😷 ✅ Avoid Large Gatherings Needed for Pfizer's profit margin for sure.
FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster ProposalThe Biden administration has planned to launch a booster shot campaign for the general public as early as next week.
Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster ProposalThe Biden administration has planned to launch a booster shot campaign for the general public as early as next week. good But if the goal is to eradicate the virus and it’s replication/mutation not just prevent serious illness / disease why not booster?